Cloning and expression of the complement receptor glycoprotein C from Herpesvirus simiae (herpes B virus): Protection from complement-mediated cell lysis

Journal of General Virology

Volumn 84, Issue 5, 2003, Pages 1091-1100

  Huemer, Hartwig P ^a,b   Wechselberger, Christian ^b,e   Bennett, Alice M ^d   Falke, Dietrich ^c   Harrington, Lesley ^d  

^a UNIVERSITY OF INNSBRUCK   (Austria)

^b ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d PUBLIC HEALTH ENGLAND   (United Kingdom)

^e Upper Austrian Research GmbH   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; COMPLEMENT COMPONENT C3 RECEPTOR; COMPLEMENT COMPONENT C3B; COMPLEMENT RECEPTOR; CYSTEINE; HEPARAN SULFATE; HEPARIN; PROPERDIN; PROTEIN C;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL ADHESION; CELL SURFACE; CELL SURVIVAL; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOLYSIS; GENE DELETION; GENETIC CONSERVATION; GENETIC RESISTANCE; GENETIC SUSCEPTIBILITY; HERPES SIMPLEX VIRUS 1; HERPES SIMPLEX VIRUS 2; HERPES VIRUS; IMMUNOREGULATION; MOLECULAR CLONING; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN ISOLATION; PSEUDORABIES HERPETOVIRUS; SENSITIVITY ANALYSIS; SEQUENCE ANALYSIS; SPECIES DIFFERENCE; VIRION;

AMINO ACID SEQUENCE; ANIMALS; CELL LINE; CLONING, MOLECULAR; COMPLEMENT C3B; COMPLEMENT PATHWAY, ALTERNATIVE; CYTOTOXICITY, IMMUNOLOGIC; HERPESVIRUS 1, CERCOPITHECINE; HUMANS; MOLECULAR SEQUENCE DATA; RECEPTORS, COMPLEMENT 3B; SEQUENCE ANALYSIS, DNA; TRANSFECTION; VIRAL ENVELOPE PROTEINS;

ANIMALIA; ANKARA; CERCOPITHECINE HERPESVIRUS 1; DNA VIRUSES; EQUIDAE; EQUINE HERPESVIRUS 1; HERPES; HERPESVIRIDAE; HERPETOVIRUS; HUMAN HERPESVIRUS 1; HUMAN HERPESVIRUS 2; MACACA; SIMIAE; SUID HERPESVIRUS 1; VACCINIA; VACCINIA VIRUS;

EID: 0037987832     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.18949-0     Document Type: Article

References (41)

1. Cole, J. L., Housley, G. A., Jr, Dykman, T. R., MacDermott, R. P. & Atkinson, J. P. (1985). Identification of an additional class of C3-binding membrane proteins of human peripheral blood leukocytes and cell lines. Proc Natl Acad Sci U S A 82, 859-863.
2. Cooper, N. R. (1991). Complement evasion strategies of microorganisms. Immunol Today 12, 327-331.
3. Davenport, D. S., Johnson, D. R., Holmes, G. P., Jewett, D. A., Ross, S. C. & Hilliard, J. K. (1994). Diagnosis and management of human B virus (Herpesvirus simiae) infections in Michigan. Clin Infect Dis 19, 33-41.
4. Edens, R. E., Linhardt, R. J. & Weiler, J. M. (1993). Heparin is not just an anticoagulant anymore: six and one-half decades of studies on the ability of heparin to regulate complement activity. In Complement Today (Complement Profiles), pp. 96-120. Edited by J. M. Cruse & R. E. Lewis, Jr. Basel: Karger.
5. Engels, M., Palatini, M., Metzler, A. E., Probst, U., Kihm, U. & Ackermann, M. (1992). Interactions of bovine and caprine herpesviruses with the natural and the foreign hosts. Vet Microbiol 33, 69-78.
6. Falke, D. (1961). Isolation of two variants with different cytopathic properties from a strain of herpes B virus. Virology 14, 492-495.
7. Falke, D. (1964). Serologic relationship between B virus and herpes simplex virus using complement fixation assay. Z Hyg 150, 185-193 (in German).
8. Fries, L. F., Friedman, H. M., Cohen, G. H., Eisenberg, R. J., Hammer, C. H. & Frank, M. M. (1986). Glycoprotein C of herpes simplex virus 1 is an inhibitor of the complement cascade. J Immunol 137, 1636-1641.
9. Gerber, S. I., Belval, B. J. & Herold, B. C. (1995). Differences in the role of glycoprotein C of HSV-1 and HSV-2 in viral binding may contribute to serotype differences in cell tropism. Virology 214, 29-39.
10. Griffiths, A., Renfrey, S. & Minson, T. (1998). Glycoprotein C-deficient mutants of two strains of herpes simplex virus type 1 exhibit unaltered adsorption characteristics on polarized or non-polarized cells. J Gen Virol 79, 807-812.
11. Harrington, L., Wall, L. V. & Kelly, D. C. (1992). Molecular cloning and physical mapping of the genome of simian herpes B virus and comparison of genome organization with that of herpes simplex virus. J Gen Virol 73, 1217-1226.
12. Hidaka, Y., Sakuma, S., Kumano, Y., Minagawa, H. & Mori, R. (1990). Characterization of glycoprotein C-negative mutants of herpes simplex virus type 1 isolated from a patient with keratitis. Arch Virol 113, 195-207.
13. Hidaka, Y., Sakai, Y., Toh, Y. & Mori, R. (1991). Glycoprotein C of herpes simplex virus type 1 is essential for the virus to evade antibody-independent complement-mediated virus inactivation and lysis of virus-infected cells. J Gen Virol 72, 915-921.
14. Hilliard, J. K., Black, D. & Eberle, R. (1989). Simian alphaherpesviruses and their relation to the human herpes simplex virus. Arch Virol 109, 83-102.
15. Horstmann, R. D., Pangburn, M. K. & Müller-Eberhard, H. J. (1985). Species specificity of recognition by the alternative pathway of complement. J Immunol 134, 1101-1104.
16. Huemer, H. P., Bröker, M., Larcher, C., Lambris, J. D. & Dierich, M. P. (1989). The central segment of herpes simplex virus type 1 glycoprotein C (gC) is not involved in C3b binding: demonstration by using monoclonal antibodies and recombinant gC expressed in Escherichia coli. J Gen Virol 70, 1571-1578.
17. Huemer, H. P., Larcher, C., Dierich, M. P. & Falke, D. (1992a). Factors influencing the interaction of herpes simplex virus glycoprotein C with the third component of complement. Arch Virol 127, 291-303.
18. Huemer, H. P., Larcher, C. & Coe, N. E. (1992b). Pseudorabies glycoprotein III derived from virions and infected cells binds to the third component of complement. Virus Res 23, 271-280.
19. Huemer, H. P., Larcher, C., Van Drunen Littel-van den Hurk, S. & Babiuk, L. A. (1993a). Species selective interaction of Alphaherpesvirinae with the 'unspecific' immune system of the host. Arch Virol 130, 353-364.
20. Huemer, H. P., Wang, Y., Garred, P., Koistinen, V. & Oppermann, S. (1993b). Herpes simplex virus glycoprotein C: molecular mimicry of complement regulatory proteins by a viral protein. Immunology 79, 639-647.
21. Huemer, H. P., Nowotny, N., Crabb, B. S., Meyer, H. & Hübert, P. H. (1995). gp13 (EHV-gC): a complement receptor induced by equine herpesviruses. Virus Res 37, 113-126.
22. Huemer, H. P., Strobl, B., Shida, H. & Czerny, C. P. (2000a). Induction of recombinant gene expression in stably transfected cell lines using attenuated vaccinia virus MVA expressing T7 RNA polymerase with a nuclear localisation signal. J Virol Methods 85, 1-10.
23. Huemer, H. P., Strobl, B. & Nowotny, N. (2000b). Use of apathogenic vaccinia virus MVA expressing EHV-1 gC as basis of a combined recombinant MVA/DNA vaccination scheme. Vaccine 18, 1320-1326.
24. Huemer, H. P., Larcher, C., Czedik-Eysenberg, T., Nowotny, N. & Reifinger, M. (2002). Fatal infection of a pet monkey with human herpesvirus. Emerg Infect Dis 8, 639-642.
25. Ikeda, K., Wakimoto, H., Ichikawa, T., Jhung, S., Hochberg, F. H., Louis, D. N. & Chiocca, E. A. (2000). Complement depletion facilitates the infection of multiple brain tumors by an intravascular, replication-conditional herpes simplex virus mutant. J Virol 74, 4765-4775.
26. Isaacs, S. N., Kotwal, J. & Moss, B. (1992). Vaccinia virus complement-control protein prevents antibody-dependent complement-enhanced neutralization of infectivity and contributes to virulence. Proc Natl Acad Sci U S A 89, 628-632.
27. Laquerre, S., Argnani, R., Anderson, D. B., Zucchini, S., Manservigi, R. & Glorioso, J. C. (1998). Heparan sulfate proteoglycan binding by herpes simplex virus type 1 glycoproteins B and C, which differ in their contributions to virus attachment, penetration, and cell-to-cell spread. J Virol 72, 6119-6130.
28. Liang, X., Babiuk, L. A. & Zamb, T. J. (1992). An in vivo study of a glycoprotein gIII-negative bovine herpesvirus 1 (BHV-1) mutant expressing β-galactosidase: evaluation of the role of gIII in virus infectivity and its use as a vector for mucosal immunization. Virology 189, 629-639.
29. Maeda, K., Hayashi, S., Tanioka, Y., Matsumoto, Y. & Otsuka, H. (2002). Pseudorabies virus (PRV) is protected from complement attack by cellular factors and glycoprotein C (gC). Virus Res 84, 79-87.
30. McNearney, T. A., Odell, C., Holers, V. M., Spear, P. G. & Atkinson, J. P. (1987). Herpes simplex virus glycoproteins gC-1 and gC-2 bind to the third component of complement and provide protection against complement-mediated neutralization of viral infectivity. J Exp Med 166, 1525-1535.
31. Medof, M. E., Kinoshita, T. & Nussenzweig, V. (1984). Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes. J Exp Med 160, 1558-1578.
32. Mettenleiter, T. C., Schreurs, C., Zuckermann, F., Ben-Porat, T. & Kaplan, A. S. (1988). Role of glycoprotein gIII of pseudorabies virus in virulence. J Virol 62, 2712-2717.
33. Moffat, J. F., Zerboni, L., Kinchington, P. R., Grose, C., Kaneshima, H. & Arvin, A. M. (1998). Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J Virol 72, 965-974.
34. Norcott, J. P. & Brown, D. W. G. (1993). Competitive radio-immunoassay to detect antibodies to herpes B virus and SA8 virus. J Clin Microbiol 31, 931-935.
35. Ohmann, H. B. & Babiuk, L. A. (1988). Induction of receptors for complement and immunoglobulins by herpesviruses of various species. Virus Res 9, 335-342.
36. Rother, R. P., Rollins, S. A., Fodor, W. L., Albrecht, J. C., Setter, E., Fleckenstein, B. & Squinto, S. P. (1994). Inhibition of complement-mediated cytolysis by the terminal complement inhibitor of herpesvirus saimiri. J Virol 68, 730-737.
37. Sawitzky, D., Hampl, H. & Habermehl, K. O. (1990). Comparison of heparin-sensitive attachment of pseudorabies virus (PRV) and herpes simplex virus type 1 and identification of heparin-binding PRV glycoproteins. J Gen Virol 71, 1221-1225.
38. Scheiflinger, F., Falkner, F. G. & Dorner, F. (1996). Evaluation of the thymidine kinase (tk) locus as an insertion site in the highly attenuated vaccinia MVA strain. Arch Virol 141, 663-669.
39. Skinner, G. R. B., Ahmad, A. & Davies, J. A. (2001). The infrequency of transmission of herpesviruses between humans and animals: postulation of an unrecognised protective host mechanism. Comp Immunol Microbiol Infect Dis 24, 255-269.
40. Spear, G. T., Lurain, N. S., Parker, C. J., Ghassemi, M., Payne, G. H. & Saifuddin, M. (1995). Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV). J Immunol 155, 4376-4381.
41. Yu, J., Dong, S., Rushmere, N. K., Morgan, B. P., Abagyan, R. & Tomlinson, S. (1997). Mapping the regions of the complement inhibitor CD59 responsible for its species selective activity. Biochemistry 36, 9423-9428.